SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025
SINTX Technologies (NASDAQ: SINT), a company specializing in biomedical applications of silicon nitride, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025 in New York City.
CEO Eric Olson will outline the company's growth strategy, discuss near-term milestones, and explain the impact of their silicon nitride platform in medical device and infection-prevention markets. The presentation will also cover recent financial initiatives, including their warrant inducement plan.
SINTX Technologies (NASDAQ: SINT), azienda specializzata nelle applicazioni biomediche del nitruro di silicio, presenter脿 al H.C. Wainwright 27掳 Annual Global Investment Conference il 9 settembre 2025 a New York.
Il CEO Eric Olson illustrer脿 la strategia di crescita dell鈥檃zienda, parler脿 dei traguardi a breve termine e spiegher脿 l鈥檌mpatto della piattaforma a base di nitruro di silicio nei settori dei dispositivi medici e della prevenzione delle infezioni. La presentazione affronter脿 inoltre le recenti iniziative finanziarie, incluso il loro piano di induzione a warrant.
SINTX Technologies (NASDAQ: SINT), compa帽铆a especializada en aplicaciones biom茅dicas del nitruro de silicio, presentar谩 en la H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre de 2025 en la ciudad de Nueva York.
El CEO Eric Olson expondr谩 la estrategia de crecimiento de la empresa, comentar谩 los hitos a corto plazo y explicar谩 el impacto de su plataforma de nitruro de silicio en los mercados de dispositivos m茅dicos y prevenci贸n de infecciones. La presentaci贸n tambi茅n abordar谩 las recientes iniciativas financieras, incluido su plan de inducci贸n de warrants.
SINTX Technologies (NASDAQ: SINT), 鞁るΜ旖� 雮橃澊韸鸽澕鞚措摐鞚� 靸濎潣頃欖爜 鞚戩毄鞚� 鞝勲鞙茧 頃橂姅 須岇偓臧� H.C. Wainwright 鞝�27須� 鞐半 旮�搿滊矊 鞚鸽矤鞀ろ姼毹柬姼 旎嵓霟办姢鞐愳劀 2025雲� 9鞗� 9鞚� 雺挫殨鞐愳劀 氚滍憸頃╇媹雼�.
CEO 鞐愲Ν 鞓姩鞚� 須岇偓鞚� 靹膘灔 鞝勲灥鞚� 靹る獏頃橁碃 雼赴 氇╉憸霌れ潉 雲检潣頃橂┌, 鞚橂旮瓣赴 氚� 臧愳椉 鞓堧癌 鞁滌灔鞐愳劀 鞁るΜ旖� 雮橃澊韸鸽澕鞚措摐 頂岆灚韽检澊 氙胳箻電� 鞓來枼鞚� 靹る獏頃� 鞓堨爼鞛呺媹雼�. 氚滍憸鞐愳劀電� 鞗岆煱韸� 鞙犽弰 瓿勴殟鞚� 韽暔頃� 斓滉芳 旮堨湹 臁办箻霌る弰 雼る０ 鞓堨爼鞛呺媹雼�.
SINTX Technologies (NASDAQ: SINT), soci茅t茅 sp茅cialis茅e dans les applications biom茅dicales du nitrure de silicium, pr茅sentera lors de la H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre 2025 脿 New York.
Le PDG Eric Olson exposera la strat茅gie de croissance de l鈥檈ntreprise, 茅voquera les jalons 脿 court terme et expliquera l鈥檌mpact de leur plateforme en nitrure de silicium sur les march茅s des dispositifs m茅dicaux et de la pr茅vention des infections. La pr茅sentation couvrira 茅galement les r茅centes initiatives financi猫res, y compris leur plan d鈥檌nduction de warrants.
SINTX Technologies (NASDAQ: SINT), ein Unternehmen, das sich auf biomedizinische Anwendungen von Siliziumnitrid spezialisiert hat, wird auf der H.C. Wainwright 27th Annual Global Investment Conference am 9. September 2025 in New York City pr盲sentieren.
CEO Eric Olson wird die Wachstumsstrategie des Unternehmens darlegen, kurzfristige Meilensteine besprechen und die Bedeutung ihrer Siliziumnitrid鈥慞lattform f眉r den Markt der Medizinprodukte und der Infektionspr盲vention erl盲utern. Die Pr盲sentation behandelt au脽erdem j眉ngste finanzielle Ma脽nahmen, einschlie脽lich ihres Warrant鈥慖nducement鈥慞lans.
- None.
- None.
SALT LAKE CITY, Utah, Sept. 09, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (鈥淪INTX鈥� or the 鈥淐ompany鈥�), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si鈧僋鈧�), today announced that it has been invited to present at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8鈥�10, 2025, at the Lotte New York Palace Hotel in New York City. The Company鈥檚 presentation is scheduled for Tuesday, September 9, 2025.
鈥淭his event provides an important opportunity to share our objectives, highlight our progress, and engage directly with the institutional investor community,鈥� said Eric Olson, Chairman and Chief Executive Officer.
Conference Objectives
At H.C. Wainwright, SINTX intends to outline its growth strategy, near-term milestones, and the broader impact of its silicon nitride platform across medical device and infection-prevention markets. The Company will also discuss how recent financial initiatives, including the warrant inducement plan, are expected to accelerate its ability to pursue strategic objectives.
Presentation & Meetings
- Date: September 9, 2025
- Format: Company presentation and one-on-one investor meetings
- Access: Conference attendees may access details via the H.C. Wainwright conference platform
For more information, visit .
About SINTX Technologies, Inc.
Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Through innovation and strategic partnerships, SINTX continues to expand its portfolio across multiple markets. For more information on SINTX Technologies or its materials platform, visit聽.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the Company鈥檚 commercialization strategy, growth plans, anticipated milestones, expectations regarding the impact of its silicon nitride platform, and the potential benefits of recent financial initiatives. Forward-looking statements are based on management鈥檚 current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Factors that may cause such differences include, among others, risks related to the Company鈥檚 ability to successfully implement its strategic objectives, achieve commercialization, obtain necessary financing, establish and maintain partnerships, and market acceptance of its products. Additional risks and uncertainties are described in the Company鈥檚 filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. SINTX undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Business and Media Inquiries for SINTX:
Elliot Sloane
ThroughCo Communications
917-291-0833
Katie Russo
ThroughCo Communications
501-282-5069
SINTX Technologies, Inc.
801.839.3502
FAQ
When is SINTX Technologies (SINT) presenting at the H.C. Wainwright Conference?
What topics will SINTX Technologies cover at the H.C. Wainwright Conference?
Who will represent SINTX Technologies at the H.C. Wainwright Conference?
How can investors access SINTX Technologies' presentation at the H.C. Wainwright Conference?
